Psyched: Top Psychedelics Execs., 50% Of Americans Support Medical Psychedelics, Cary Grant’s LSD Therapy & More
15 Global Psychedelics Executives To Keep An Eye On In 2022
Psyched: CA’s Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More
Alberta Becomes The First Canadian Province To Regulate Psychedelics-Assisted Therapy
Ketamine Therapy At Your Doorstep, Growing Number Of Clinics Offer This Treatment Option
Being the sole psychedelic legally available as medicine, ketamine-assisted therapy services are expanding at a rapid pace across the U.S.
Wellbeing Digital Reports 4Q Finances, ‘Three Key Pillars’ Stay Strong
Wellbeing Digital Sciences Inc. (OTC: KONEF) filed its financial results for the quarter ended July 31, 2022 and provided some insight on their most recent businesses.
Numbers for the selected period showed:
World Class Leaders In Psychedelics Form Benzinga’s Psychedelic Advisory Council—Get To Know Them
The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business landscape.
Wellbeing Digital Introduces Women In Psychedelics, A Network For Female Minds In Psychedelics
Mental healthcare company Wellbeing Digital Sciences Inc. (OTC: KONEF) and its subsidiary KGK Science Inc. are the founding sponsors of the Women in Psychedelics Network, also known as “WIP.”
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS:
Mind Medicine (NASDAQ:MNMD) shares closed up 11.18% at $1.03
Wellbeing Digital, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS:
Wellbeing Digital (OTC:KONEF) shares closed up 148.45% at $0.40
LOSERS:
Psychedelic Stock Gainers And Losers From March 7, 2022
GAINERS:
GH Research (NASDAQ:GHRS) shares closed up 1.49% at $15.71
LOSERS:
Psychedelic Stock Gainers And Losers From March 4, 2022
GAINERS:
Wellbeing Digital (OTC:KONEF) shares closed up 258.43% at $0.52